Anti-EGFR (Epidermal Growth Factor Receptor) Antibody BHA10200915

Mfr.No.	1956-MSM8-P0
Alternative Names	Erbb1 ; ERBB1 ; Errp ; HER1 ; mENA ; PIG61 ; Proto-oncogene c-ErbB-1 ; Receptor Tyrosine Protein Kinase ; ErbB1 ; Urogastrone
Categories	Primary Antibodies
Cellular Localization	Cell Surface
Chromosome Location	7p11.2
Clonality	Monoclonal
Description	This MAb recognizes a protein of 170kDa, identified as EGFR. EGFR is type I receptor tyrosine kinase with sequence homology to erbB-1, -2, -3 -4 or HER-1, -2, -3 -4. It binds to Epidermal Growth Factor (EGF), Transforming Growth Factor-a (TGF-a), Heparin-binding EGF (HB-EGF), amphiregulin, betacellulin and epiregulin. EGFR is overexpressed in tumors of breast, brain, bladder, lung, gastric, head & neck, esophagus, cervix, vulva, ovary, and endometrium. It is predominantly present in squamous cell carcinomas.
Host	Mouse
Immunogen	Recombinant human full-length EGFR protein
Isotype	IgG1
Positive Control	A431 cells. Placenta, Breast, Colon or Bladder cancer
Reactivity	Human
Recombinant	FALSE
Regulatory	RUO

Swissprot	P00533
Uniprot	488293
Gene Id	1956

Buffer	200μg/ml of Ab purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1mg/ml.
Concentration	200µg/ml
Description	There are no warranties, expressed or implied, which extend beyond this description. Company is not liable for any personal injury or economic loss resulting from this product.
Purity	Purified Ab with BSA and Azide at 200μg/ml

Applications

FACS, IF, IHC-F

Description

(Staining of formalin-fixed tissues requires boiling tissue sections in 10mM citrate buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined., FACS ; IF ; IHC-F

Dilution